Connecting you to content on EBSCOhost

Works matching IS 00079235 AND DT 2024 AND VI 74 AND IP 5

Results: 6

1

Osimertinib prolongs progression‐free lung cancer survival after chemotherapy.

Published in:

CA: A Cancer Journal for Clinicians, 2024, v. 74, n. 5, p. 402, doi. 10.3322/caac.21862

By:

Fillon, Mike

Publication type:

Article

2

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019.

Published in:

CA: A Cancer Journal for Clinicians, 2024, v. 74, n. 5, p. 405, doi. 10.3322/caac.21858

By:

Islami, Farhad;
Marlow, Emily C.;
Thomson, Blake;
McCullough, Marjorie L.;
Rumgay, Harriet;
Gapstur, Susan M.;
Patel, Alpa V.;
Soerjomataram, Isabelle;
Jemal, Ahmedin

Publication type:

Article

3

Cancer disparities for LGBTQ+ patients identified more fully.

Published in:

CA: A Cancer Journal for Clinicians, 2024, v. 74, n. 5, p. 399, doi. 10.3322/caac.21861

By:

Fillon, Mike

Publication type:

Article

4

Cancer misinformation on social media.

Published in:

CA: A Cancer Journal for Clinicians, 2024, v. 74, n. 5, p. 453, doi. 10.3322/caac.21857

By:

Loeb, Stacy;
Langford, Aisha T.;
Bragg, Marie A.;
Sherman, Robert;
Chan, June M.

Publication type:

Article

5

The evolving landscape of tissue‐agnostic therapies in precision oncology.

Published in:

CA: A Cancer Journal for Clinicians, 2024, v. 74, n. 5, p. 433, doi. 10.3322/caac.21844

By:

Subbiah, Vivek;
Gouda, Mohamed A.;
Ryll, Bettina;
Burris, Howard A.;
Kurzrock, Razelle

Publication type:

Article

6

Issue Information.

Published in:: CA: A Cancer Journal for Clinicians, 2024, v. 74, n. 5, p. 397, doi. 10.3322/caac.21798
Publication type:: Article